IANS Pfizer, which has struck a nearly $2-billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval “as early as October” this year and have a vaccine in the market by the yearend. A “best case […]